Ritalin

Novartis Pharmaceuticals Corporation🇺🇸 United States

FDA Page

Effective Date: Oct 13, 2023
Approval ID: effd952d-ac94-47bb-b107-589a4934dcca
Products: 4 registered
Version: 33

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA (methylphenidate hydrochloride) extended-release capsules for oral use, CIIInitial U.S. Approval: 1955

Quick Stats

Total Products4

Labelers2

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.